Related Experiment Video
Updated: Mar 19, 2026
08:40
Spatial and Temporal Analysis of Active ERK in the C. elegans Germline
Published on: November 29, 2016
10.9K
Negative feedback regulation of the ERK1/2 MAPK pathway
David Lake1, Sonia A L Corrêa2,3, Jürgen Müller4,5
1Warwick Medical School, University of Warwick, Coventry, UK.
Cellular and Molecular Life Sciences : CMLS
|June 26, 2016
Summary
Negative feedback loops control the extracellular signal-regulated kinase 1/2 (ERK1/2) mitogen-activated protein kinase (MAPK) pathway. Understanding these mechanisms is crucial for developing effective cancer treatments targeting ERK1/2 signaling.
Area of Science:
- Molecular Biology
- Cell Signaling
- Cancer Biology
Background:
- The extracellular signal-regulated kinase 1/2 (ERK1/2) pathway is vital for cellular functions like proliferation and differentiation.
- Proper integration of ERK1/2 signaling into cellular networks is essential for adapting to environmental changes.
- Dysregulation of ERK1/2 signaling is implicated in uncontrolled cell growth and malignant transformation.
Purpose of the Study:
- To review and analyze the negative feedback mechanisms governing the ERK1/2 mitogen-activated protein kinase (MAPK) pathway.
- To elucidate how these feedback loops modulate the spatiotemporal dynamics of ERK1/2 signaling.
- To discuss the implications of ERK1/2 feedback regulation in cancer therapy and drug resistance.
Main Methods:
- Review of existing literature on ERK1/2 MAPK signaling.
- Analysis of negative feedback loops, including posttranslational modifications and gene induction.
- Evaluation of the impact of feedback on signaling amplitude, duration, and localization.
Main Results:
- Extensive negative feedback loops target multiple components of the ERK1/2 pathway.
- Negative feedback regulates signaling amplitude, duration, and subcellular localization of ERK1/2.
- Aberrant ERK1/2 activation is a hallmark of many human tumors.
Conclusions:
- Negative feedback is critical for shaping ERK1/2 signaling dynamics.
- Understanding ERK1/2 feedback mechanisms is essential for improving cancer treatment strategies.
- Feedback regulation contributes to therapeutic challenges, including drug resistance in cancer therapy.
Related Concept Videos
01:07MAPK Signaling Cascades
9.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.1K
01:19Interactions Between Signaling Pathways
7.8K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.8K
01:31Regulation of the Unfolded Protein Response
3.2K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.2K
01:22PI3K/mTOR/AKT Signaling Pathway
6.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.2K
01:22Amplifying Signals via Enzymatic Cascade
19.0K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.0K
01:37The Unfolded Protein Response
6.7K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.7K